carvedilol has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Y | 2 |
| Li, J | 2 |
| Luo, Y | 2 |
| Ma, J | 2 |
| Huang, P | 2 |
| Chen, Y | 2 |
| He, Z | 2 |
1 other study available for carvedilol and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Carvedilol; Caspase 3; Cell Line, Tumor; Cell Prolifera | 2023 |
Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Carvedilol; Caspase 3; Cell Line, Tumor; Cell Prolifera | 2023 |
Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Carvedilol; Caspase 3; Cell Line, Tumor; Cell Prolifera | 2023 |
Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Carvedilol; Caspase 3; Cell Line, Tumor; Cell Prolifera | 2023 |